Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.
2.

[Diagnostic structured interviews in child and adolescent's psychiatry].

Renou S, Hergueta T, Flament M, Mouren-Simeoni MC, Lecrubier Y.

Encephale. 2004 Mar-Apr;30(2):122-34. Review. French.

PMID:
15107714
3.

Psychiatric and medical comorbidities of bipolar disorder.

Krishnan KR.

Psychosom Med. 2005 Jan-Feb;67(1):1-8. Review.

PMID:
15673617
4.

The empirical basis of generalized anxiety disorder.

Brown TA, Barlow DH, Liebowitz MR.

Am J Psychiatry. 1994 Sep;151(9):1272-80. Review.

PMID:
8067480
5.

Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.

Brady KT, Sinha R.

Am J Psychiatry. 2005 Aug;162(8):1483-93. Review.

PMID:
16055769
7.

Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC.

Hasin D, Kilcoyne B.

Curr Opin Psychiatry. 2012 May;25(3):165-71. doi: 10.1097/YCO.0b013e3283523dcc. Review.

8.

Commentary, special issue, Journal Of Gambling Studies.

Nathan PE.

J Gambl Stud. 2005 Fall;21(3):355-61. Review. No abstract available.

PMID:
16134012
9.

DSM-V research agenda: substance abuse/psychosis comorbidity.

Rounsaville BJ.

Schizophr Bull. 2007 Jul;33(4):947-52. Epub 2007 Jun 7. Review.

10.

Assessing addiction: concepts and instruments.

Samet S, Waxman R, Hatzenbuehler M, Hasin DS.

Addict Sci Clin Pract. 2007 Dec;4(1):19-31. Review.

11.

Non-psychotic mental disorders in the perinatal period.

Howard LM, Molyneaux E, Dennis CL, Rochat T, Stein A, Milgrom J.

Lancet. 2014 Nov 15;384(9956):1775-88. doi: 10.1016/S0140-6736(14)61276-9. Epub 2014 Nov 14. Review.

PMID:
25455248
12.

Mood disorders and substance use disorder: a complex comorbidity.

Quello SB, Brady KT, Sonne SC.

Sci Pract Perspect. 2005 Dec;3(1):13-21. Review.

13.

Transitioning from DSM-IV to DSM-5: A systematic review of eating disorder prevalence assessment.

Lindvall Dahlgren C, Wisting L.

Int J Eat Disord. 2016 Nov;49(11):975-997. doi: 10.1002/eat.22596. Epub 2016 Aug 16. Review.

PMID:
27528542
14.

DSM-III axis IV revisited.

Rey JM, Stewart GW, Plapp JM, Bashir MR, Richards IN.

Am J Psychiatry. 1988 Mar;145(3):286-92. Review.

PMID:
3278630
15.

Clinically useful assessments: substance use and comorbid psychiatric disorders.

Carey KB.

Behav Res Ther. 2002 Nov;40(11):1345-61. Review.

PMID:
12384329
16.

Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry.

Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD.

Trends Cogn Sci. 2012 Jan;16(1):81-91. doi: 10.1016/j.tics.2011.11.009. Epub 2011 Dec 10. Review.

PMID:
22155014
17.
18.

Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future.

Frances AJ, Widiger T.

Annu Rev Clin Psychol. 2012;8:109-30. doi: 10.1146/annurev-clinpsy-032511-143102. Epub 2011 Oct 25. Review.

PMID:
22035240
19.

Detection of substance use disorders in severely mentally ill patients.

Drake RE, Alterman AI, Rosenberg SR.

Community Ment Health J. 1993 Apr;29(2):175-92; discussion 193-4. Review.

PMID:
8500289
20.

Age of onset of mental disorders: a review of recent literature.

Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ust√ľn TB.

Curr Opin Psychiatry. 2007 Jul;20(4):359-64. Review.

Supplemental Content

Support Center